Surgical outcomes and strict follow-up of retroperitoneal soft-tissue sarcoma

Date 29 June 2016
Event ESMO World Congress on Gastrointestinal Cancer 2016
Session ESMO World Congress on Gastrointestinal Cancer 2016 - Abstracts book
Presenter A. Chiappa
Citation Annals of Oncology (2016) 27 (2): 1-85. 10.1093/annonc/mdw199
Authors A. Chiappa1, E. Bertani2, A. Zbar3, D. Foschi4, F. Luca5, M. Venturino2, N. Fazio6, C. Ferrari7, I. Monsellato8, R. Biffi6
  • 1University of Milan -European Institute of Oncology, Milan, Italy, /
  • 2European Institute of Oncology, Milan, Italy, /
  • 3Department of General Surgery and Transplantation, Tel Aviv, Israel, /
  • 4Department of Surgery, Oncology and Gastroenterology - Division of General Surgery - A.O. Luigi Sacco - University of Milan, Milan, Italy, /
  • 5Unit of Surgical Multidisciplinary Techniques - European Institute of Oncology, Milan, Italy, /
  • 6European Institute of Oncology, Milano, Italy, /
  • 7University of Milan, Milan, Italy, /
  • 8Division of Digestive Tract Surgery, Milan, Italy, /

Abstract

Treatment and survival features in a consecutive series of 89 patients affected by primary or recurrent retroperitoneal sarcoma (RPS) were reported. Eighty-three among them underwent resection and all of them were treated and strictly followed-up.